Gallotta A - Search Results

1

Current evidence and future perspectives about the role of iXip® in the diagnosis of prostate cancer.

Antonelli A, Francavilla S, Gallotta A, Da Pozzo LF, Ferretti S, Sigala S, Simeone C, Mirone V, Artibani W, Porreca A. Antonelli A, et al. Among authors: gallotta a. Minerva Urol Nefrol. 2019 Jun;71(3):201-204. doi: 10.23736/S0393-2249.19.03329-0. Epub 2019 Feb 14. Minerva Urol Nefrol. 2019. PMID: 30767493 Free article. Review.

2

A novel algorithm for the prediction of prostate cancer in clinically suspected patients.

Gallotta A, Ziglioli F, Ferretti S, Maestroni U, Moretti M, Aloe R, Gnocchi C, Di Palo M, Fassina G. Gallotta A, et al. Cancer Biomark. 2013;13(4):227-34. doi: 10.3233/CBM-130357. Cancer Biomark. 2013. PMID: 24240583

3

Clinical evaluation of the iXip index to reduce prostate re-biopsies.

Galosi AB, Dell'Atti L, Bertaccini A, Gion M, Francavilla S, Ferretti S, Maestroni U, Gallotta A, Parrozzani C, Paneghetti L, Fassina G. Galosi AB, et al. Among authors: gallotta a. Cancer Treat Res Commun. 2018;16:59-63. doi: 10.1016/j.ctarc.2018.07.001. Epub 2018 Jul 19. Cancer Treat Res Commun. 2018. PMID: 31299004

4

Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients.

Beneduce L, Prayer-Galetti T, Giustinian AM, Gallotta A, Betto G, Pagano F, Fassina G. Beneduce L, et al. Among authors: gallotta a. Cancer Detect Prev. 2007;31(5):402-7. doi: 10.1016/j.cdp.2007.10.005. Epub 2007 Nov 26. Cancer Detect Prev. 2007. PMID: 18035503

5

Lectin-based lateral flow assay: proof-of-concept.

Damborský P, Koczula KM, Gallotta A, Katrlík J. Damborský P, et al. Among authors: gallotta a. Analyst. 2016 Nov 14;141(23):6444-6448. doi: 10.1039/c6an01746k. Analyst. 2016. PMID: 27767199

6

Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis.

Zuin J, Veggiani G, Pengo P, Gallotta A, Biasiolo A, Tono N, Gatta A, Pontisso P, Toth R, Cerin D, Frecer V, Meo S, Gion M, Fassina G, Beneduce L. Zuin J, et al. Among authors: gallotta a. Clin Chem Lab Med. 2010 Feb;48(2):217-23. doi: 10.1515/CCLM.2010.044. Clin Chem Lab Med. 2010. PMID: 20001440

7

HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients.

Martini A, Fattovich G, Guido M, Bugianesi E, Biasiolo A, Ieluzzi D, Gallotta A, Fassina G, Merkel C, Gatta A, Negro F, Pontisso P. Martini A, et al. Among authors: gallotta a. J Viral Hepat. 2015 Oct;22(10):800-8. doi: 10.1111/jvh.12394. Epub 2015 Jan 22. J Viral Hepat. 2015. PMID: 25611978 Free article.

8

Characterization of SCCA-IgM as a biomarker of liver disease in an Asian cohort of patients.

Bui Huu H, Ha Thuc N, Thi Le HP, Thi Thanh TD, Luong Bac A, Tiribelli C, Pontisso P, Gallotta A, Paneghetti L, Fassina G. Bui Huu H, et al. Among authors: gallotta a. Scand J Clin Lab Invest. 2018 May;78(3):204-210. doi: 10.1080/00365513.2018.1432072. Epub 2018 Jan 30. Scand J Clin Lab Invest. 2018. PMID: 29381084

9

Combinatorial semisynthesis of biomarker-IgM complexes.

Veggiani G, Zuin J, Beneduce L, Gallotta A, Pengo P, Fassina G. Veggiani G, et al. Among authors: gallotta a. J Biomol Screen. 2010 Dec;15(10):1274-80. doi: 10.1177/1087057110378623. Epub 2010 Oct 11. J Biomol Screen. 2010. PMID: 20938047

10

Solid-phase preparation of protein complexes.

Pengo P, Veggiani G, Rattanamanee K, Gallotta A, Beneduce L, Fassina G. Pengo P, et al. Among authors: gallotta a. J Mol Recognit. 2010 Nov-Dec;23(6):551-8. doi: 10.1002/jmr.1095. J Mol Recognit. 2010. PMID: 21038355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page